On February 13, 2024, Invacare Holdings Corporation representing more than a majority of the voting power of the Company?s issued and outstanding capital stock acted by written consent in lieu of a special meeting of stockholders to, among other things, appoint Samuel Brill, Jame Donath and J. Carney Hawks as directors of the Company. In connection therewith, Steven Rosen, Randel Owen and Peter Kuipers were removed and will no longer be serving on the Board of Directors of the Company as of February 13, 2024. Mr. Brill has more than 25 years of experience in capital markets, corporate finance, investment banking and business operations.

Since August 2017, he has served as the President and Chief Investment Officer of Seventh Avenue Investments, the private equity arm of a single-family office in New York City with a multibillion-dollar asset portfolio. Mr. Brill has served on numerous public and private boards and committees. Currently he serves as the Lead Independent Director and Chair of the Compensation and Governance Committee of Ascend Wellness Holdings and he has served on the Investment Committee of NewLake Capital Partners, a publicly traded REIT.

Mr. Brill was previously the Chief Investment Officer and Portfolio Manager of Weismann Capital and the Chief Operating Officer and a Director of Amedia Networks (formerly TTR Technologies). Mr. Donath is a seasoned investor and advisor who regularly serves in non-executive corporate director roles. Some of Mr. Donath?s recent board positions include Nordic Aviation Capital, Vice Media, Venator Materials, Resolute Investment Managers, and Keter Group.

Mr. Donath spent over 20 years as an investor in corporate credit opportunities as Managing Partner of Magnolia Road Capital LLC and as a Managing Director with Davidson Kempner Capital Management, where he launched the firm?s European credit business. Mr. Donath started his career in the investment banking division of Goldman Sachs & Co. Mr. Donath received a B.A. in Economics from Yale University and an MBA from Harvard Business School.

Mr. Hawks was a Founding Partner of Brigade Capital Management, a multi-billion dollar asset management firm, from its inception in 2007 until his retirement from the company in December 2019. At Brigade, Mr. Hawks was the Head of Special Situations, sat on the firm?s Investment Committee and helped oversee many of Brigade?s restructured equities as a Board member or Board advisor. Prior to Brigade, Mr. Hawks was a Managing Director at Mackay Shields in its High Yield Group.

Since his time with Brigade, Mr. Hawks has sat on the boards of numerous companies following their restructurings including Cenveo Worldwide and Extraction Oil and Gas. Mr. Hawks is currently the Chairman of the Board of Cornerstone Chemical Company and also a Director of Ferrellgas Partners, LP. Mr. Hawks also serves as Treasurer and a board member of the Children?s Cardiomyopathy Foundation and is on the Advisory Board to the McIntire School of Commerce at the University of Virginia where he earned a Bachelor of Science in Commerce with Distinction.

In connection with the appointment of the New Directors, Mr. Brill was appointed Chairman of the Board and Mr. Donath was appointed Vice Chairman of the Board.